DiscovertouchPODCASTManaging cytopenias: The path to transfusion independence for patients with myelofibrosis
Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

Update: 2025-12-05
Share

Description

touchIN CONVERSATION for touchHAEMATOLOGY


The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors.


The experts



  • Prof. Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

  • Dr Laura Fox, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain


This touchPODCAST is for HCPs outside of the USA.


This activity is supported by an independent medical education grant from GSK.


This activity is provided by touchIME in collaboration with our Education Partner Haematology Nurses & Healthcare Professionals Group (HNHCP).


touchIME is an EBAC® accredited provider.


For further information visit our website: www.touchHAEMATOLOGY.com

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

touchPODCAST